Suchergebnisse - "Pagsberg, Anne Katrine"

PubPharm (10)

1

A Meta-Analysis of Antipsychotic-Induced Hypo- and Hyperprolactinemia in Children and Adolescents

enthalten in: Journal of child and adolescent psychopharmacology | 2022

von Krøigaard, S. | Clemmensen, L. | Tarp, S. | +1

2

Early Antipsychotic Nonresponse as a Predictor of Nonresponse and Nonremission in Adolescents With Psychosis Treated With Aripiprazole or Quetiapine : Results From the TEA Trial

enthalten in: Journal of the American Academy of Child and Adolescent Psychiatry | 2022

von Pagsberg, A. | Krogmann, A. | Jeppesen, P. | +10

CommentIn: J Am Acad Child Adolesc Psychiatry. 2022 Aug;61(8):968-971. - PMID 35470031

3

CYP2D6 Genotyping and Antipsychotic-Associated Extrapyramidal Adverse Effects in a Randomized Trial of Aripiprazole Versus Quetiapine Extended Release in Children and Adolescents, Aged 12-17 Years, With First Episode Psychosis

enthalten in: Journal of clinical psychopharmacology | 2021

von Rudå, D. | Jensen, K. | Decara, M. | +9

4

Cardiometabolic Adverse Effects and Its Predictors in Children and Adolescents With First-Episode Psychosis During Treatment With Quetiapine-Extended Release Versus Aripiprazole : 12-Week Results From the Tolerance and Effect of Antipsychotics in Children and Adolescents With Psychosis (TEA) Trial

enthalten in: Journal of the American Academy of Child and Adolescent Psychiatry | 2019

von Jensen, K. | Correll, C. | Rudå, D. | +7

CommentIn: J Am Acad Child Adolesc Psychiatry. 2019 Nov;58(11):1051-1053. - PMID 30928730

5

Change and dispersion of QT interval during treatment with quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis : results from the TEA trial

enthalten in: Psychopharmacology | 2018

von Jensen, K. | Gärtner, S. | Correll, C. | +8

6

Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis : the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial

enthalten in: The lancet. Psychiatry | 2017

von Pagsberg, A. | Jeppesen, P. | Klauber, D. | +20

CommentIn: Lancet Psychiatry. 2017 Aug;4(8):576-577. - PMID 28748790

7

Neurological, Metabolic, and Psychiatric Adverse Events in Children and Adolescents Treated With Aripiprazole

enthalten in: Journal of clinical psychopharmacology | 2016

von Jakobsen, K. | Bruhn, C. | Pagsberg, A. | +2

8

Quetiapine versus aripiprazole in children and adolescents with psychosis--protocol for the randomised, blinded clinical Tolerability and Efficacy of Antipsychotics (TEA) trial

enthalten in: BMC psychiatry | 2014

von Pagsberg, A. | Jeppesen, P. | Klauber, D. | +26

9

Quetiapine versus aripiprazole in children and adolescents with psychosis - protocol for the randomised, blinded clinical Tolerability and Efficacy of Antipsychotics (TEA) trial

enthalten in: BMC psychiatry | 2014

von Pagsberg, A. | Jeppesen, P. | Klauber, D. | +26

10

Quetiapine versus aripiprazole in children and adolescents with psychosis - protocol for the randomised, blinded clinical Tolerability and Efficacy of Antipsychotics (TEA) trial

enthalten in: BMC psychiatry | 2014

von Pagsberg, A. | Jeppesen, P. | Klauber, D. | +26

1
[1]